Products
Preparation registered in Ukraine
Svyntsytskii A., Soloviova H., Kvacheniuk K., Dolgaia N.
Defenorm in treatment of irritable bowel syndrome with constipation
Conclusions of Defenorm efficacy study (drug produced by “Kyiv Vitamin Factory”) involving 98 patients with irritable bowel syndrome (IBS), accompanied by constipation, were that Defenorm contributes to pain and constipation evaporation in the majority of patients with IBS with constipation on the 3rd day of treatment at a dose of 2 capsules TID. During treatment with Defenorm improvement of bacteriological indicators of the stool was observed: increasing the number of bifidus and lactobacillus, reducing the amount of pathogenic flora. Defenorm promotes normalization of scintigraphy that characterizes normalization of intestinal transit.
Key words: irritable bowel syndrome, constipation, fecal bacteriological indicators, bifidus and lactobacilli, conditionally pathogenic flora of intestine, scintigraphy, Defenorm.